|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,120.00 KRW | -1.54% |
|
+1.19% | +0.39% |
| 12/23/12 | Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 19/22/19 | Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index | CI |
| Capitalization | 7.48TCr 5.11Cr 4.38Cr 4.08Cr 3.8Cr 7.09Cr 461.11Cr 7.64Cr 47Cr 18Cr 220.58Cr 19Cr 19Cr 808.26Cr | P/E ratio 2023 |
-42.3x | P/E ratio 2024 | -28.9x |
|---|---|---|---|---|---|
| Enterprise value | 7.16TCr 4.89Cr 4.19Cr 3.91Cr 3.63Cr 6.78Cr 441.25Cr 7.31Cr 45Cr 18Cr 211.08Cr 18Cr 18Cr 773.45Cr | EV / Sales 2023 |
5.61x | EV / Sales 2024 | 3.31x |
| Free-Float |
58.91% | Yield 2023 * |
-
| Yield 2024 | - |
More valuation ratios
* Estimated data
More news
| 1 day | -1.54% | ||
| 1 week | +1.19% | ||
| Current month | +0.39% | ||
| 1 month | -1.54% | ||
| 3 months | +3.43% | ||
| 6 months | +0.59% | ||
| Current year | +0.39% |
| 1 week | 4,955 |  | 5,280 |
| 1 month | 4,950 | | 5,300 |
| Current year | 4,950 | | 5,280 |
| 1 year | 4,755 | | 6,250 |
| 3 years | 4,400 | | 9,680 |
| 5 years | 4,400 | | 17,950 |
| 10 years | 4,400 | | 31,150 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 54 | 01/04/2019 |
Beom-Gu Han
PRN | Corporate Officer/Principal | 57 | 24/03/2022 |
Ki-Myung Choi
PRN | Corporate Officer/Principal | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hyun-Il Kim
BRD | Director/Board Member | 54 | 26/03/2019 |
Ki-Myung Choi
BRD | Director/Board Member | 54 | - |
Hyeon-Wuk Choi
BRD | Director/Board Member | 51 | 24/03/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54% | +1.19% | -0.97% | -27.07% | 5.13Cr | |
| +0.98% | +0.14% | -23.46% | -21.80% | 5.55TCr | |
| -0.04% | +7.01% | +108.89% | +86.85% | 1.21TCr | |
| -1.10% | -0.22% | -25.35% | +4.89% | 397.95Cr | |
| 0.00% | -0.28% | +13.54% | +40.27% | 351.96Cr | |
| -0.29% | +7.39% | +165.34% | +67.64% | 271.11Cr | |
| -0.38% | -2.43% | -21.11% | +0.45% | 180.34Cr | |
| -1.46% | +1.12% | +96.60% | +171.41% | 161.61Cr | |
| -0.55% | +2.05% | +12.68% | +4.79% | 129.65Cr | |
| -1.61% | -0.75% | +24.92% | -37.69% | 115.98Cr | |
| Average | -0.60% | +1.03% | +35.11% | +28.97% | 837.37Cr | |
| Weighted average by Cap. | +0.51% | +1.17% | +6.92% | +5.13% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 1.74TCr 1.19Cr 1.02Cr 94.76L 88.18L 1.65Cr 107.07Cr 1.77Cr 11Cr 4.29Cr 51Cr 4.45Cr 4.36Cr 187.68Cr | 1.96TCr 1.34Cr 1.15Cr 1.07Cr 99.67L 1.86Cr 121.02Cr 2.01Cr 12Cr 4.84Cr 58Cr 5.03Cr 4.92Cr 212.13Cr |
| Net income | -243.67Cr -16.64L -14.28L -13.29L -12.37L -23.08L -15Cr -24.88L -1.53Cr -60.12L -7.18Cr -62.39L -61.1L -26Cr | -235.66Cr -16.09L -13.81L -12.85L -11.96L -22.32L -15Cr -24.06L -1.48Cr -58.14L -6.95Cr -60.34L -59.1L -25Cr |
| Net Debt | -560.46Cr -38.26L -32.83L -30.57L -28.45L -53.09L -35Cr -57.23L -3.51Cr -1.38Cr -17Cr -1.44Cr -1.41Cr -61Cr | -322.27Cr -22L -18.88L -17.58L -16.36L -30.53L -20Cr -32.91L -2.02Cr -79.51L -9.5Cr -82.51L -80.81L -35Cr |
More financial data
* Estimated data
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 5,120.00 ₩ | -1.54% | 16,019 |
| 13/26/13 | 5,200.00 ₩ | +2.56% | 41,913 |
| 12/26/12 | 5,070.00 ₩ | +0.20% | 19,798 |
| 09/26/09 | 5,060.00 ₩ | +0.80% | 9,616 |
| 08/26/08 | 5,020.00 ₩ | -0.79% | 9,840 |
End-of-day quote Korea S.E., January 14, 2026
More quotes
- Stock Market
- Equities
- A153710 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition